VP1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

494 results for “VP1”

Trials

View all 284 →

A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek

202 participants · First posted May 14, 2021

Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines

30 participants · First posted May 6, 2021

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

66 participants · First posted Apr 24, 2017

Drugs

View all 157 →

VP1-001

TP1

AP1

Organizations

VR1 Corporation

United States

VPI Pharmaceuticals Inc

Canada

News

View all 51 →

Vaxart's Oral Norovirus Vaccine Shows Promising Immune Response in Elderly Phase 1b Trial

Lexeo Therapeutics to Showcase Advanced AAV Manufacturing Platform at ASGCT Annual Meeting

Norovirus Vaccine Development Advances with mRNA and Oral Tablet Candidates

Page 1 of 50